Evidence map›Paper›PMID 34679474›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Clinical Uses and Short-Term Safety Profile of Ethiodized Poppy Seed Oil Contrast Agent in the Diagnosis and Treatment of Vascular Anomalies and Tumors.

Robert K Clemens, Tim Sebastian, Cindy Kerr, Ahmad I Alomari

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Embolic Agents: Sclerotherapy.Seminars in interventional radiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Robert K ClemensVascular Center, Cantonal Hospital Baden, CH-5404 Baden, Switzerland.
Tim SebastianClinic for Angiology, University Hospital Zurich and University Zurich, CH-8091 Zurich, Switzerland.ORCID 0000-0003-0446-2862
Cindy KerrDepartment of Radiology and Vascular Anomalies Center, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Ahmad I AlomariDepartment of Radiology and Vascular Anomalies Center, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Boston Children's Hospital · USUniversity Hospital of Zurich · CH

Funding

Guerbert, France and USA Personal Grant
6 · The paper itself

Abstract

backgroundThere is a sparsity of data on the use of ethiodized poppy seed oil (EPO) contrast agent (Lipiodol) in patients. We investigated the safety of EPO in children, adolescents, and some adults for diagnostic and therapeutic interventions.

methodsAll patients who underwent procedures with EPO between 1995 and 2014 were retrospectively included. Demographic characteristics, diagnosis, dose, route of administration, preparation of EPO in combination with other agents, and complications were recorded.

resultsIn 1422 procedures, EPO was used for diagnostic or treatment purposes performed in 683 patients. The mean patient age was 13.4 years (range: 2 months-50 years); 58% of patients were female. Venous malformations (

conclusionThe use of an ethiodized poppy seed oil contrast agent in children, adolescents, and adults for diagnostic or therapeutic purposes is safe.

Indexed as

embolizationEPOethiodized poppy seed oilsafetysclerotherapyvascular malformation

Identifiers

PMID34679474
PMCPMC8534402
OpenAlexW3202008087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.